Trials / Completed
CompletedNCT04341012
Breath Analysis Based Disease Biomarkers
Development of a Breath Analysis Test for Disease Diagnosis and Prognosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.
Detailed description
The study will seek to collect and analyze breath samples from a broad range of patients to develop reference ranges and to refine the testing methods. Protocols for breath sample collection and algorithms for analysis will be developed. Samples will be collected from normal volunteers, persons with documented liver disease, organ transplant or with known COVID-19 test results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Collection of breath sample | Analysis of volatile organic compounds in breath |
Timeline
- Start date
- 2019-09-10
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
- First posted
- 2020-04-10
- Last updated
- 2026-01-26
- Results posted
- 2024-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04341012. Inclusion in this directory is not an endorsement.